BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models - Concepedia

Concepedia

Publication | Open Access

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models

DOI Full Paper Access

23

Citations

62

References

2024

Year

Ulrike Rauh, Wei Guo, Michael H. Serrano‐Wu, Georgios Kosmidis, Franziska Siegel, Kai Thede, James M. McFarland, Christopher T. Lemke, Nicolas D. Werbeck, Katrin Nowak‐Reppel,

References

	Year	Citations

Page 1